To investigate the function of nsdA in Streptomyces bingchengensis, it was cloned and sequenced, which presented an 89.89% identity with that of S. coelicolor. The kRED-mediated PCR-targeting technique was used to create nsdA replacement in the S. bingchengensis_226541 chromosome. The nsdA disruption mutant, BC29, was obtained, which produced more pigment and spores than did the ancestral strain. HPLC analysis revealed that the disruption of nsdA efficiently increased milbemycin A 4 production and nanchangmycin production by 1.5-fold and 9-fold, respectively. Complementation of the nsdA mutation restored the phenotype and antibiotic production. These results showed that nsdA negatively affected sporulation and antibiotic production in S. bingchengensis.
INTRODUCTION
Streptomyces have attracted great interest because of their well-known ability to produce a great variety of antibiotics and other secondary metabolites. 1 Secondary metabolism is a very complex regulatory network. 2 Pathway-specific regulatory genes, such as actII-orf4, redD, cdaR and mmyR, are at the bottom of the regulatory network, each controlling one antibiotic biosynthetic pathway. 3 Global regulators, such as bldA, 4 bldB, 5 bldD 6 and bldG, 7 perform the highest level regulation and affect both morphological and physiological differentiation. 8, 9 At intermediate levels in the regulatory cascades, many regulatory genes, such as afsB, 10 abaA, 11 absB, 12 afsK-afsR 13, 14 and tcrA, 15 and two-component systems, such as afsQ1-afsQ2, 16 absA1-absA2, 17, 18 cutS-cutR 19 and phoR-phoP, 20 have been identified, which regulate the synthesis of two or more antibiotics. absA1-absA2, cutScutR, phoR-phoP, tcrA and some pathway-specific repressors regulate antibiotic production in a negative manner, as mutations in these genes resulted in the overproduction of the corresponding antibiotic(s). Global regulators may also play a negative role, as in the case of the A-factor receptor protein, ArpA, in Streptomyces griseus. When A-factor is absent, ArpA binds to the adpA promoter and represses the expression of AdpA, which is an activator of a regulon that consists of operons involved in mycelial differentiation and antibiotic production. The arpA-null mutants produced more streptomycin and formed aerial hyphae earlier than the wild-type strain did. [21] [22] [23] Recent microarray data have indicated a cross-regulation among disparate antibiotic biosynthetic pathways and even some backregulation from cluster-situated regulators to a ''higher level'' pleiotropic regulatory gene. 24 These studies showed that regulating antibiotic biosynthesis and mycelial differentiation is important for understanding the factors affecting antibiotic yield.
Among the many regulatory genes, nsdA was able to negatively control sporulation and antibiotic production, which was first found in Streptomyces coelicolor A3(2) in 2006. 25 Subsequent studies showed that nsdA is widely existent and conserved in Streptomyces, such as S. hygroscopicus 10B22, S. spiecies FR-008, S. lividans ZX64, S. aureofaciens 211, S. albus JA3453, S. hygroscopicus 5008, S. avermitilis NRRL8165 and S. coelicolor M145. 26 The disruption of chromosomal nsdA resulted in the overproduction of spores and three of four known S. coelicolor antibiotics of different chemical types. 26 It suggested that nsdA might have some general effects on antibiotic production. However, the function of nsdA was less investigated.
The S. bingchengensis used in this study was isolated from soil samples collected from Harbin, China. As a novel strain, S. bingchengensis produces at least two kinds of antibiotics, the polyether nanchangmycin and macrolide compound milbemycins, A 3 and A 4 , (Figure 1 ). In addition, it also generates new milbemycins, b 13 , b 14 , a 28 , a 29 a 30 , and two new seco-milbemycins. [27] [28] [29] The mixture of milbemycins A 3 and A 4 was marketed as an acaricide for the control of mites in 1990. 30 Subsequently, in animal health fields, 5-oxime derivatives of milbemycins, A 3 and A 4 , were found to be highly effective as anthelmintics and were marketed. However, nanchangmycin is an antibiotic that affects cation transport, and is effective in treating coccidiosis in chickens. 31 The identification of new genes that regulate antibiotic biosynthesis and mycelial differentiation is important for understanding the factors affecting antibiotic yield. In this study, we report the identification of a new gene, nsdA, negatively affecting both processes. In light of our results, we propose a novel view of improving the output of milbemycins and nanchangmycin in S. bingchengensis.
MATERIALS AND METHODS

Microorganisms, cloning vectors and cultivation
For routine subcloning, Eschericha coli DH5a was cultivated and transformed according to the method of Sambrook et al. 32 ET12567 was used to propagate unmethylated DNA for introduction into Streptomyces bingchengensis_226541 by transformation or conjugation. E. coli BW25113/pIJ790 (gifts from Professor Andrew Hesketh) was the host for lRED-mediated PCR-targeting mutagenesis. pIJ773 was used as the template for the amplification of a disruption cassette containing the apramycin resistance gene, aac(3)IV, and the RK2 origin of transfer (oriT), flanked by recognition sites for FLP recombinase. 33 E. coliStreptomyces shuttle plasmid, pHZ1358 (provided by Dr Yinghua Zheng), was used to construct the nsdA gene-replacement vector. pIJ8600, which integrated into the S. bingchengensis_226541 chromosome by site-specific recombination at the bacteriophage FC31 attachment site, attB, 34, 35 was used to introduce single copies of genes into the S. bingchengensis_226541 chromosome.
S. bingchengensis was isolated from soil samples collected in Harbin, China. S. bingchengensis has been stored at the China General Microbiology Culture Collection Center (accession no.: CGMCC1734), and the 16S rDNA sequence was determined (accession no.: DQ449953 in National Center for Biological Information). Several Streptomyces media were used. MS agar 36 was used to make spore suspensions and for plating-out conjugations with E. coli ET12567 containing the RP4 derivative, pUZ8002. 37 R2YE was used for protoplast transformation. 36 Yeast extract-malt extract was a liquid medium. 36 All Streptomyces cultivations were carried out at 30 1C.
Genetic procedures
Standard genetic procedures with E. coli and in vitro DNA manipulations were carried out as described by Sambrook et al. 32 Recombinant DNA manipulations in the Streptomyces species and isolation of genomic DNA were performed as described by Kieser et al. 36 DNA restriction and modifying enzymes were used as recommended by the manufacturers (BRL, Carlsbad, CA, USA and Takara Biotechnology Ltd Company, Dalian, China). DNA fragments were purified from agarose gels with the Geneclean kit II (BIO101, Beijing, China).
DNA sequencing and analysis
Primers were designed by using the data obtained from the S. coelicolor and S. avermitilis genome sequences. 25 Total DNA was isolated from S. bingchengensis_226541, 36 and a DNA fragment containing a coding region for the nsdA was amplified with nsdA R (5¢-CCTCGGCGAAGATGTCCTCC-3¢) and nsdA L (5¢-TCTCCGTCGAGGACCTGGGC-3¢) primers. The amplified fragment was ligated into a pMD18-T vector to obtain the recombinant plasmid, pBC106. Then, nsdA was subcloned into the BglII site of an E. coli-Streptomyces shuttle plasmid, pHZ1358, to obtain pBC118, with nsdA 2L (5¢-TCGAGATCTG TACGCGGGGATC-3¢, wherein underlined letters indicate restriction sites) and nsdA 2R (5¢-GCATGCCTGCAGATCTACGATC-3¢). Thereafter, pBC118 was used as a template for the following PCR mutagenesis experiments. Subclone sequencing was performed by Takara Biotechnology Ltd Company. DNA and deduced protein sequences were analyzed using publicly available programs at the following websites: http://www.ncbi.nlm.nih.gov/blast/, http:// watson.nih.go.jp/~jun/cgi-bin/frameplot-3.0b.pl and http://motif.genome.jp/.
nsdA replacement and verification
The nsdA gene replacement vector was constructed by lRED-mediated PCRtargeting mutagenesis. 33, 38 Two PCR primers, BC-nsdA-F and BC-nsdA-R, corresponding to the regions upstream and downstream of the nsdA coding region (underlined), respectively, were used to amplify aac(3)IV+oriT from pIJ773.
BC-nsdA-F: 5¢-CCGCCGCGGCTTCCTCGGCACCTCGCTCGCGCTCTCC GCATTCCGGGGATCCGTCGACC-3¢ BC-nsdA-R: 5¢-GCGAAGGTGTCCTCGGCCATCCGCACGGCCCGCTTG CACTGTAGGCTGGAGCTGCTTC-3¢ The amplified fragment was used to replace the nsdA in pBC118. The resulting plasmid, named pBC929, was verified by PCR and restriction analysis, and then passed through the non-methylating E. coli ET12567/pUZ8002 before reintroduction into S. bingchengensis_226541 by conjugation. The gene mutant was verified by PCR analysis.
In the complementation experiments, the intact nsdA fragments were amplified by the primers, P3 (5¢-GAAGATCTCCTCGTTACCTCCATCAC-3¢, where underlined letters indicate restriction sites) and P4 (5¢-GAAGATCT TCTGCACGCTGTCGGCCT-3¢), and then inserted into the BamHI site of pIJ8600 to give pJC3. The resulting vectors were introduced into the nsdA disruption mutant.
Fermentation and analysis of antibiotic production
The seed for preculture was spores. The medium for sporulation contained sucrose 4.0 g, yeast extract 2.0 g, malt extract 5.0 g and skimmed milk powder 1.0 g in 1 l water. The pH was adjusted to 7.0 with 1 M NaOH, 20 g of agar was added and this mixture was sterilized at 121 1C for 30 min. The spore suspension was prepared from agar plates incubated at 28 1C for 7-8 days.
A spore suspension of the culture of S. bingchengensis, 1.0 ml, was transferred to a 250-ml Erlenmeyer flask that contained 25 ml of the seed medium comprising sucrose 0.25 g, polypeptone 0.1 g and K 2 HPO 4 1.25 mg. The To analyze milbemycin A4 and nanchangmycin titer, the samples were collected from fermentation flasks and processed for milbemycin extraction by mixing one volume of the whole culture with five volumes of ethanol and sonicated at room temperature for 30 min. The samples were centrifuged at 3250 g for 10 min and the supernatant was analyzed by HPLC using a 5-ml particle size NOVA-PAK (Waters, Milford, MA, USA) column (3.9Â150 mm) eluted at a flow rate of 1.5 ml min À1 with a 15-min linear gradient from 0 to 90% (V/V) of phase B. Phase A was MeCN-H 2 O-MeOH (350:50:100, V/V/V) and phase B was MeOH. Chromatography was performed with a SHIMADZU LC-2010CHT HPLC system (Shimadzu Corporation, Kyoto, Japan) and detection was at 242 nm. As standard for antibiotic titer determination, a sample of milbemycin A4 (100 mg ml À1 ) and nanchangmycin (200 mg ml À1 ) was used. The peak positions for milbemycin A4 and nanchangmycin were determined compared with those for the standard compounds.
RESULTS
DNA sequencing and analysis
The nucleotide sequence of the 1.5-kb DNA fragment was amplified by PCR. Sequence analysis showed that the 1485-bp DNA fragment encoded a 494-amino-acid protein (GenBank EU779992), which shared 89.89% identity in the nucleotide sequence and 97.82% similarity at the amino-acid level compared with those of S. coelicolor (Table 1) .
Replacement of nsdA gene
To understand the function of nsdA, the gene replacement vector, pBC929, was constructed using lRED-mediated PCR-targeting mutagenesis, 33 and then conjugated into S. bingchengensis_226541. The mutant strains were selected using apramycin and thiostrepton. Seven apramycin-resistant and thiostrepton-resistant (Am R Tsr R ) strains (named BC19) were obtained from conjugation plates, indicating the single cross-over events. Three apramycin-resistant and thiostrepton-sensitive (Am R Tsr S ) strains (named BC29) were obtained from conjugation plates, implying the loss of the plasmid by a second homologous recombination. Gene replacement events were confirmed by PCR using the nsdA2L-nsdA2R primers with genomic DNA from S. bingchengensis_226541 and gene disruptants. The expected 1.5-kb nsdA fragment was amplified from the S. bingchengensis_226541 genome by PCR. The PCR products from the double-cross-over recombination mutant, BC29, were larger than those from the ancestral strain by about 0.5 kb in size. However, the single-crossover recombination mutant, BC19, has both 1.5-and 2-kb gene fragments. These results showed that the nsdA was replaced precisely by an oriT+aac(3) IV in the homologous double-cross-over recombination mutant.
Phenotype of nsdA disruption mutant
The nsdA disruption mutant, BC29, was different from the ancestral strain in the rate and extent of sporulation. When cultured on an MS medium, the mutant BC29 began to produce a yellow pigment at 36 h, which was about 24 h earlier than that by S. bingchengensis_226541. The nsdA disruption mutant, BC29, gave rise to abundant gray spores grown for 72 h, whereas the ancestral strain produced white aerial hyphae at this time. Both pigment amounts and eventual sporulation levels in the mutant BC29 seemed to be greater than those of the ancestral strain (Figure 2 ). When we plated out diluted spores harvested from colonies on the MS medium grown for 10 days and counted the colony, BC29 spore suspensions reproducibly formed about twice as many colonies as did S. bingchengensis_226541.
All the phenotypic changes of the nsdA disruption mutant, BC29, were complemented by introducing pJC3, excluding potential polar effects on adjacent genes or an additional mutation in BC29 as alternative explanations. These results suggested that nsdA played a negative role in S. bingchengensis_226541 morphological differentiation.
Enhanced production of two antibiotics in nsdA disruption mutant HPLC assays on the nsdA disruption mutant, BC29, revealed that disruption of nsdA remarkably increased antibiotic production. Milbemycin A 4 production increased from 670 to 1005 mg ml À1 , whereas nanchangmycin production improved from 230 to 2070 mg ml À1 . The yield of milbemycin A 4 and nanchangmycin increased by 1.5-and 9-fold, respectively (Figure 3 ). The change of milbemycin and nanchangmycin production was reversed to the ancestral level by the introduction of nsdA back into BC29 (data not shown), excluding potential polar effects on adjacent genes as an explanation. It inferred that nsdA had repressed the production of milbemycins and nanchangmycin by S. bingchengensis_226541.
DISCUSSION
In this paper, nsdA in S. bingchengensis_226541 was identified, which encoded a 483-amino-acid protein that shared a 97.82% sequence identity with the NsdA of S. coelicolor. Blast searching indicated that there was an ortholog with sequence identity over 80% to each of these NsdA ortholog proteins in Streptomyces. NsdA contained a conserved domain, DUF921, which was defined as a Streptomyces protein domain of unknown function. Proteins containing the DUF921 domain included several putative regulatory proteins from S. coelicolor and S. griseus. 39 A search in the superfamily server also revealed that NsdA and other homologous proteins in Streptomyces had tetratricopeptide repeat-like repeats, 40 which mediated proteinprotein interactions. 41 We are currently using an E. coli two-hybrid system to seek NsdA-interacting proteins. The disruption of the SCO4114 homologous gene, which had earlier been shown to prevent premature sporulation septation of S. griseus, had no obvious phenotypic effects on S. bingchengensis (data not shown). Possibly, there are differences in the manner deployed in the two species. nsdA negatively affects both antibiotic biosynthesis and mycelial differentiation. The repressing effect was obvious even when the nsdA gene was disrupted. Gene disruption mutant, BC29, showed abundant gray spores in contrast to the white phenotype of the ancestral strain, and markedly increased the yield of milbemycin A 4 and nanchangmycin. In view of the fact that the structures of milbemycin A 4 and nanchangmycin are quite unlike each other, this result suggested that nsdA might have some general effects on secondary metabolism. As the disruption of chromosomal nsdA resulted in higher productions of Act, CDA, Mmy and spores in S. coelicolor, actII-orf4 mRNA was increased in an nsdA mutant, suggesting that the negative effect of nsdA on Act biosynthesis was exerted at the level of transcription of the pathway-specific activator gene. 25, 42 Although the genomic library of S. bingchengensis is under way, the new transcription factors, including pathway-specific regulators of milbemycin A 4 and nanchangmycin biosynthesis cluster, will be identified, which may be correlated with nsdA, suppressing antibiotic production. The elucidation of correlations between nsdA and its corresponding factors could be helpful in enhancing antibiotic yield. 
